摘要 |
<p>The present invention relates to the treatment of EGFR-mediated disease, particularly cancer by inhibiting or blocking EGFR and src in combination or simultaneously. The invention relates to treatment, prevention, or modulation of cancer, particularly EGFR- mediated disease, with one or more EGFR modulator and src inhibitor in combination. The invention further relates to the treatment of cancer with anti-EGFR antibodies and src inhibitors. Methods and compositions for treatment of cancer with the antibody anti- EGFR mAb806 in combination or series with a src inhibitor or src inhibitors are described.</p> |
申请人 |
LUDWING INSTITUTE FOR CANCER RESEARCH;CAVENEE, WEBSTER;FURNARI, FRANK;JOHNS, TERRANCE, GRANT;SCOTT, ANDREW |
发明人 |
CAVENEE, WEBSTER;FURNARI, FRANK;JOHNS, TERRANCE, GRANT;SCOTT, ANDREW |